This was not due to downregulation of mesothelin because its expression was confirmed ex vivo; however, PET imaging using 89Zr-anti-meosthelin ADC showed reduced tumor uptake in the unresponsive pancreatic cancer models. This evidence concerns the gene MSLN and neoplasm.